There is considerable discourse about the UK PA project, so hoped it’d be helpful to distill info into 🧵 s
1: History of the PAs in the UK
2: Comparison of US vs UK PA courses
3: Breakdown of the PA Framework
4: Study of the PARA Content Map
5: Costs of employing PAs vs Drs
1/
@ZiaYusufUK@JonathanPieNews Breast cancer is more common in European ancestry. It forms part of national screening here because we’re a white-majority country.
Also do you know who Ashkenazi Jews are? They’re generally considered white and boy, do I have news for you regarding specific screening for them…
@Alison6123@medicalmodelbri@BSMSMedSchool She has an MSc.
It’s the questionable “top up” MSc where you write an essay and hey presto! Add the credits to your PGDip to “upgrade”.
And then become an instant professor by setting up another dubious course.
The whole PA debacle makes serious academia look like a joke.
@Megsenmumdr@medicalmodelbri@BSMSMedSchool@gmcuk I think they were all doing it during a phase. Was Bascome not previously Straughton? Or are they two different people, I can’t remember.
Straughton was a big player in the RCP circuit. She peddled the idea of equivalence of membership exams IIRC.
@JamesDeroest@JonathanPieNews Proband risk is different to population screening.
Proband risk also applies to most types of cancer and is and should be approached differently.
@oOoOoO0o00oO@wetindiswahala@JonathanPieNews Btw, 1 in 25 Northern European people are carriers for CF.
Compare that to 1 in 4 black men getting prostate cancer.
Hopefully you can understand why there is a difference in approach.
@oOoOoO0o00oO@wetindiswahala@JonathanPieNews There’s no screening test for MS.
CF is tested for where there’s family history of CF, there’s genetic counselling clinics for it.
Skin cancer - rapid access services and massive info campaigns. Can’t do prospective screening.
AD - No reliable screening test but regularly tested.